The 23andMe Research Institute bought the company's assets for $305 million, scotching a proposed sale to Regeneron ...

A judge has finally approved the bankruptcy sale of 23andme, and its data, to a nonprofit owned by 23andme's founder. That means that if you have data stored with the site, it's basically staying in ...

-Regeneron Pharmaceuticals has declined to submit a new bid for genetic testing company 23andMe exceeding its original winning bid of $256 million, a company spokesperson told Reuters on Monday. WHY ...

When the mail-in ancestry company 23andMe filed for bankruptcy, Regeneron Pharmaceuticals stepped in to snap it up. Though in the end the Tarrytown-based company was outbid, the scenario raised a ...

Regeneron Pharmaceuticals (NASDAQ:REGN) has reportedly declined to submit a higher bid for 23andMe (OTC:MEHCQ) after a non-profit led by the company’s co-founder and former CEO Anne Wojcicki proposed ...

A bankruptcy judge approved the sale of genetics company 23andMe to a non-profit led by co-founder and former CEO Anne Wojcicki, according to a June 27 filing in the bankruptcy docket. TTAM Research ...

From the San Francisco Business Times. 23andMe co-founder Anne Wojcicki is back in control of the genetic-testing company. A nonprofit led by Wojcicki — who launched the consumer DNA-test industry and ...

23andMe on Tuesday announced it will voluntarily delist from the Nasdaq and de-register with the U.S. Securities and Exchange Commission, according to a release. Stream Connecticut News for free, 24/7 ...

A bankruptcy judge has approved the sale of the insolvent genetics firm 23andMe to a nonprofit run by one of the company's co-founders. The deal effectively avoids the controversial transfer of DNA ...

New York and other states filed a lawsuit seeking to block 23andMe, the bankrupt genetic testing firm, from selling millions of Americans' genetic data to the highest bidder. A total of 28 state ...